MDCalc

Utah COVID-19 Risk Score

Identifies high-risk individuals who are appropriate for COVID-19 treatment (updated February 2022).

Launched during COVID-19 crisis. Not externally validated. Use with caution; this is being used in Utah for assessment, trending, and treatment recommendations.

Per the Utah Department of Health & Human Services, certain patient populations automatically qualify for COVID-19 treatment and do not need to be evaluated with this tool, including:

  • Residence of long-term care, skilled nursing, or correctional facilities.
  • Unvaccinated individuals ≥75 years of old.
  • Those with a severe immunocompromising condition (see guidelines for specific definitions). 

This score should be used only for those who do not automatically qualify.

Demographic risk factors

Age, years

Highest risk comorbidities

Diabetes mellitus

Obesity (BMI >30 kg/m2)

Other high risk comorbidities

Active cancer

Other immunosuppressive therapies and conditions

Includes methotrexate, hydroxychloroquine, leflunomide, chronic corticosteroids, TNF inhibitors, IL 12/23 inhibitors, IL-17 inhibitors, IL-1 inhibitors, integrin inhibitors, and immunotherapy

Hypertension

Coronary artery disease

Cardiac arrhythmia

Congestive heart failure

Chronic kidney disease

Chronic pulmonary disease

Chronic liver disease

Cerebrovascular disease

Includes strokes and transient ischemic attacks, sometimes called “mini strokes”

Chronic neurologic disease

Includes MS, Parkinson’s disease, dementia/other neurodegenerative conditions, and myasthenia gravis

Do not mark as yes for migraines, local neuropathies, or fibromyalgia unless also positive for previously listed conditions

Symptom risk factor

New shortness of breath

Result:

Please fill out required fields.
Advice

This tool should complement, not replace, clinical judgment and should be used alongside a thorough history and clinical evaluation, only during periods of therapeutic scarcity.

Management

According to the Utah Department of Health & Human Services, a patient qualifies for antiviral treatment if:

  • They meet all inclusion criteria, including:
    • COVID-19 is confirmed by PCR or antigen testing.
    • They are symptomatic with symptom onset ≤10 days prior.
    • They have no new hypoxemia.
    • They are not currently admitted or being admitted to an acute care hospital for COVID-19 or related complications.
  • Their risk score is:
    • ≥8 if vaccinated.
    • ≥6 if unvaccinated/incompletely vaccinated.
    • ≥4 if unvaccinated/incompletely vaccinated and pregnant.

For more details, please refer to the 2022 Utah Crisis Standards of Care Scarce COVID Therapeutics Allocation Guidelines.

Have feedback about this calculator?